ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Tocagen inks commercialisation deal with ApolloBio
April 23, 2018Under the terms of the deal, Tocagen will receive $16M upfront, $4M in near-term milestones, up to $111M in future milestones and tiered low double-digit royalties on net sales. -
Tocagen Receives European Medicines Agency Orphan Medicinal Product Designation for Toca 511 & Toca
March 08, 2018Tocagen Inc. today announced the EMA has granted orphan medicinal product designation to Toca 511 (vocimagene amiretrorepvec) & Toca FC for the treatment of patients with glioma, a type of brain tumor.
Pharma Sources Insight January 2025
